Randomization is stratified :~angiosarcoma in irradiated region : yes / no~visceral angiosarcoma : yes / no~All patient will received a maximum of 6 cycles of weekly Paclitaxel (Arm A and B) in association or not with Bevacizumab (ArmB).~1 cycle = 28 days Treatment by Bevacizumab is to continue beyond the 6th cycle, until disease progression or unacceptable toxicity~Arm A and B:~Day 1, D8 and D15 Paclitaxel : 90 mg/m², IV weekly with premedication~Arm B :~Day 1 and D15 Bevacizumab : 10 mg/kg and then, Bevacizumab : 15 mg/kg/3 weeks until disease progression or unacceptable toxicity
Efficacity of Paclitaxel in association or not with Bevacizumab in treatment of angiosarcoma